Versant Capital Management, Inc Surmodics Inc Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in Surmodics Inc stock. As of the latest transaction made, Versant Capital Management, Inc holds 6 shares of SRDX stock, worth $176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6
Previous 6
-0.0%
Holding current value
$176
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SRDX
# of Institutions
140Shares Held
12.1MCall Options Held
31.3KPut Options Held
17.9K-
Black Rock Inc. New York, NY1.17MShares$34.5 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY849KShares$25 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$23.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT789KShares$23.3 Million1.99% of portfolio
-
Morgan Stanley New York, NY676KShares$19.9 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $413M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...